EA201990885A1 - Композиции, содержащие короткие пептиды, полученные из pedf, и их применение - Google Patents

Композиции, содержащие короткие пептиды, полученные из pedf, и их применение

Info

Publication number
EA201990885A1
EA201990885A1 EA201990885A EA201990885A EA201990885A1 EA 201990885 A1 EA201990885 A1 EA 201990885A1 EA 201990885 A EA201990885 A EA 201990885A EA 201990885 A EA201990885 A EA 201990885A EA 201990885 A1 EA201990885 A1 EA 201990885A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pedf
application
compositions containing
short peptides
peptides obtained
Prior art date
Application number
EA201990885A
Other languages
English (en)
Other versions
EA037698B1 (ru
Inventor
Куаньинь Карен Линь
Йоу-Пин Тсао
Тсун-Чуань Хо
Фрэнк Вэнь-Чи Ли
Original Assignee
Брим Байотекнолоджи, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Брим Байотекнолоджи, Инк. filed Critical Брим Байотекнолоджи, Инк.
Publication of EA201990885A1 publication Critical patent/EA201990885A1/ru
Publication of EA037698B1 publication Critical patent/EA037698B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/515—Angiogenesic factors; Angiogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

Фармацевтическая композиция для лечения офтальмологического заболевания у субъекта включает пептид и фармацевтически приемлемый наполнитель, где пептид содержит последовательность SEQ ID NO: 1: S-X-X-A-X-Q/H-X-X-X-X-I/V-I-X-R, где каждый X независимо представляет собой любую аминокислоту.
EA201990885A 2016-10-07 2017-08-24 Композиции, содержащие короткие пептиды, полученные из pedf, и их применение EA037698B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662405522P 2016-10-07 2016-10-07
PCT/US2017/048340 WO2018067244A1 (en) 2016-10-07 2017-08-24 Compositions comprising pedf-derived short peptides and uses thereof

Publications (2)

Publication Number Publication Date
EA201990885A1 true EA201990885A1 (ru) 2019-08-30
EA037698B1 EA037698B1 (ru) 2021-05-12

Family

ID=61831898

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201990885A EA037698B1 (ru) 2016-10-07 2017-08-24 Композиции, содержащие короткие пептиды, полученные из pedf, и их применение

Country Status (10)

Country Link
US (1) US11760784B2 (ru)
EP (1) EP3596104A4 (ru)
JP (2) JP2019533722A (ru)
KR (2) KR20230169375A (ru)
CN (1) CN110312732A (ru)
AU (2) AU2017340245B2 (ru)
EA (1) EA037698B1 (ru)
IL (1) IL265796A (ru)
TW (1) TW201822785A (ru)
WO (2) WO2018067244A1 (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021521115A (ja) * 2018-04-08 2021-08-26 ブリム バイオテクノロジー インクＢｒｉｍ Ｂｉｏｔｅｃｈｎｏｌｏｇｙ， Ｉｎｃ． 変形性関節症の治療におけるｐｅｄｆ由来短鎖ペプチドの使用
TW202010513A (zh) * 2018-04-08 2020-03-16 全福生物科技股份有限公司 Pedf衍生之短肽在肌腱癒合中的應用
KR20210005696A (ko) * 2018-05-04 2021-01-14 브림 바이오테크놀로지, 인코퍼레이티드 마이봄 샘 재생을 촉진하기 위한 pedf-유래 펩타이드 및 그것의 사용
CN111632128B (zh) * 2019-02-14 2022-07-05 三凡生技研发股份有限公司 短链胜肽组合物在预防或治疗干眼症的应用
TWI759610B (zh) * 2019-06-27 2022-04-01 晶碩光學股份有限公司 具有角膜修護功能的眼用產品
TWI744683B (zh) * 2019-08-27 2021-11-01 台灣基督長老教會馬偕醫療財團法人馬偕紀念醫院 短合成胜肽及其治療視網膜退化性疾病和/或組織損傷的用途
EP4021917A4 (en) * 2019-08-27 2023-05-24 Yeou-Ping Tsao SHORT SYNTHETIC PEPTIDES AND THEIR USE IN THE TREATMENT OF RETINAL DEGENERATIVE DISEASES AND/OR TISSUE INJURIES
CN115151243A (zh) * 2019-10-06 2022-10-04 全福生物科技股份有限公司 包含pedf-衍生短肽(pdsp)的组合物及其用途
CN112206312A (zh) * 2020-11-19 2021-01-12 北京大学第三医院（北京大学第三临床医学院） 一种包含pedf的用于治疗干眼的药物组合物
CN115364199A (zh) * 2021-05-19 2022-11-22 远大医药（中国）有限公司 包含pedf衍生的短肽的组合物及其制备方法和用途
TW202402320A (zh) * 2022-06-13 2024-01-16 全福生物科技股份有限公司 用於治療乾眼疾病之包含pedf衍生短肽之組合物
TW202400628A (zh) * 2022-06-24 2024-01-01 全福生物科技股份有限公司 用於治療神經營養性角膜炎疾病之包含pedf衍生短肽之組合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6451763B1 (en) * 1992-06-04 2002-09-17 The United States Of America As Represented By The Department Of Health And Human Services Retinal pigmented epithelium derived neurotrophic factor and methods of use
US6797691B1 (en) * 1997-07-23 2004-09-28 Northwestern University Methods and compositions for inhibiting angiogenesis
AU2004285562B2 (en) * 2003-10-29 2011-06-09 The Johns Hopkins University Pigment epithelium-derived factor, novel biological activity and methods of use
US20050260180A1 (en) * 2004-03-12 2005-11-24 Genvec, Inc. Materials and methods for treating vascular leakage in the eye
EP1986676A4 (en) * 2006-02-15 2009-11-04 Univ Yale Inc COMPOSITIONS AND METHODS USING PIGMENT EPITHELIUM DERIVED FACTOR (PEDF) PEPTIDE FRAGMENTS
US20130333068A1 (en) * 2008-04-29 2013-12-12 Marie Coffin Genes and uses for plant enhancement
JP2013507373A (ja) * 2009-10-08 2013-03-04 ニューロテック ユーエスエー， インコーポレイテッド 被包された細胞ベースの送達系におけるｐｅｄｆの使用
EP2508196B1 (en) * 2011-03-23 2018-09-26 Mackay Memorial Hospital Use of PEDF-derived polypeptides for promoting stem cells proliferation and wound healing
TWI554521B (zh) * 2011-10-19 2016-10-21 台灣基督長老教會馬偕醫療財團法人馬偕紀念醫院 色素上皮衍生因子衍生之多胜肽於治療禿髮和／或毛髮脫色之用途
CA2882479C (en) * 2012-08-09 2018-07-24 Yeou-Ping Tsao Use of pedf-derived polypeptides for promoting muscle or tendon regeneration or arteriogenesis
US9815878B2 (en) * 2012-09-19 2017-11-14 Mackay Memorial Hospital Use of PEDF-derived polypeptides for preventing and/or ameliorating skin aging
AU2012390210B2 (en) * 2012-09-20 2017-06-29 Mackay Memorial Hospital Use of PEDF-derived polypeptides for treating osteoarthritis
US9611314B2 (en) * 2013-09-13 2017-04-04 The Penn State Research Foundation Functional peptide analogs of PEDF

Also Published As

Publication number Publication date
EP3596104A1 (en) 2020-01-22
EP3596104A4 (en) 2021-02-17
JP2022185042A (ja) 2022-12-13
TW201822785A (zh) 2018-07-01
WO2018067217A2 (en) 2018-04-12
US20190248859A1 (en) 2019-08-15
KR20190066030A (ko) 2019-06-12
JP2019533722A (ja) 2019-11-21
AU2017340245A1 (en) 2019-05-23
US11760784B2 (en) 2023-09-19
WO2018067244A1 (en) 2018-04-12
CN110312732A (zh) 2019-10-08
AU2017340245B2 (en) 2022-07-21
AU2022204557A1 (en) 2022-07-21
KR20230169375A (ko) 2023-12-15
EA037698B1 (ru) 2021-05-12
WO2018067217A3 (en) 2019-05-02
IL265796A (en) 2019-06-30

Similar Documents

Publication Publication Date Title
EA201990885A1 (ru) Композиции, содержащие короткие пептиды, полученные из pedf, и их применение
BR112017007816A2 (pt) composições farmacêuticas compreendendo variantes de peptídeos e métodos de uso das mesmas
MX360208B (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX363136B (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX2019006515A (es) Composiciones que comprenden peptido wkdeagkplvk.
WO2015188132A8 (en) Methods of constructing amino terminal immunoglobulin fusion proteins and compositions thereof
SI3079715T1 (en) A mixture of peptides
EA201500802A1 (ru) Способы профилактики и/или лечения кардиомиопатии и устранения симптомов кардиомиопатии, фармацевтическая композиция, векторы
EP3936141A3 (en) Anti-senescence compounds and uses thereof
MX2019006943A (es) Polipéptidos para manejo de infecciones virales.
EA202190310A1 (ru) Белок для лечения воспалительных заболеваний
EA201590601A1 (ru) Применение pedf-производных полипептидов для лечения остеоартрита
PH12020500569A1 (en) Influenza virus vaccines and uses thereof
EA202091095A1 (ru) Пероральная доставка пептидных аналогов glp-1
MX2017016227A (es) Peptidos anti-infecciosos de amplio espectro.
BR112017014737A2 (pt) formulação de peptídeos inibidores de mk2
WO2015043566A8 (de) Zyklische, amyloid-beta-bindende peptide und deren verwendung
MX2018000023A (es) Particulas semejantes a virus recombinantes que utilizan la proteina gag del virus de inmunodeficiencia bovina.
PH12018500468A1 (en) Fusion protein
MX2022002766A (es) Vacunas contra el virus de la gripe y usos de las mismas.
JP2018529625A5 (ru)
MX2017013480A (es) Composicion farmaceutica para tratar y/o prevenir el cancer.
MX2015002279A (es) Peptido pntx(19) sintético, composición farmacéutica.y uso.
WO2016205397A3 (en) Target-specific delivery of therapeutic agents
BR112018010225A2 (pt) peptídeos e sua utilização no tratamento do cabelo